Biotech Values

[urche]

CAMH

"Putting the currently available studies of microvolt TWA in LV dysfunction in perspective, it can be concluded that the predictive efficacy of the test is largely dependent on the patient population studied."

I am becoming more convinced that TWA testing measures something consistently with validity that is close to or a little better than clinical judgement (based largely on EF and history of ventricular arrhythmia), and/or EP testing which has never been much of a gold standard.

Applied to a population, the test seems to have some validity. At the risk of sounding like a curmudgeon, I remain skeptical that TWA testing is going to enjoy a role as standard of care for testing INDIVIDUAL cardiac patients.

urche